Novavax, Inc. (NVAX) financial statements and ratios from SEC XBRL: revenue $1.12B (TTM), net margin 39.2%, revenue growth -76.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.12B |
| Net Margin | 39.2% |
| Revenue Growth (YoY) | -76.3% |
| EPS Growth (YoY) | -148.5% |
| Price / Sales | 3.36 |
| Altman Z-Score | -2.05 (distress) |
| Sector P/E (Healthcare) | 21.6 |
NVAX overview · NVAX earnings · NVAX KPIs · NVAX investor relations · NVAX ownership · NVAX peers · NVAX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.